The Bioabsorbables/Bioresorbables Center

Filter Your Results

 

News

 

Postmarket Study Published on Elixir Medical's DESolve Bioresorbable Scaffold

November 27, 2018 -- Twelve-month results from the multicenter postmarket clinical follow-up study of the DESolve novolimus‐eluting bioresorbable coronary scaffold system (E…

Cordis Launches Mynx Control Vascular Closure Device

November 2, 2018 -- Cordis, a Cardinal Health company, announced the United States launch of the Mynx Control vascular closure device (VCD). The device integrates active extra…

ABSORB IV Results Reported for Abbott Vascular's Bioresorbable Vascular Stent

October 1, 2018 -- Findings from the ABSORB IV randomized trial demonstrated that the polymeric Absorb bioresorbable vascular stent (BVS; Abbott Vascular) implanted with optim…

Two-Year BIOFLOW-V Data Presented for Biotronik's Orsiro DES

September 24, 2018 -- Biotronik announced 2-year data from the BIOFLOW-V randomized trial at TCT 2018, the 30th annual Transcatheter Cardiovascular Therapeutics scientific sym…

BIONYX Evaluates Medtronic's Resolute Onyx DES With Improved Radiographic Visibility

September 22, 2018 -- Findings from the BIONYX trial were reported at TCT 2018, the 30th annual Transcatheter Cardiovascular Therapeutics scientific symposium held September 2…

Data on Reva's Fantom Bioresorbable Vascular Scaffold Presented at TCT

September 22, 2018 -- Reva Medical, Inc. announced that four key data sets evaluating the company’s Fantom bioresorbable scaffold (BRS) were presented at TCT 2018, the T…

ESC/EACTS Publish Guidelines on Myocardial Revascularization

August 28, 2018 -- The European Society of Cardiology (ESC) announced the publication of new ESC/European Association for Cardio-Thoracic Surgery (EACTS) guidelines on myocard…

A Novel, Radiopaque, Bioresorbable Tyrosine-Derived Polymer for Cardiovascular Scaffolds

Gregor Leibundgut, MD

July/August 2018—The REVA Medical Fantom bioresorbable scaffold is available under CE Mark only and is not approved in the United States. First-generation, drug-eluting, bioresorbable c…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.